nefrНефрологияNephrology (Saint-Petersburg)1561-62742541-9439Pavlov First Saint-Petersburg State Medical University10.24884/1561-6274-2009-13-3-24-32nefr-1174Research ArticleОБЗОРЫ И ЛЕКЦИИREVIEWS AND LECTURESЭНДОТЕЛИАЛЬНАЯ ДИСФУНКЦИЯ, МЕТАБОЛИЧЕСКИЙ СИНДРОМ И МИКРОАЛЬБУМИНУРИЯENDOTHELIAL DYSFUNCTION, METABOLIC SYNDROME AND MICROALBUMINURIAШишкинА. Н.ShishkinA. N.

кафедра терапии Медицинского факультета

alexshishkin@bk.ruЛындинаМ. Л.LyndinaM. L.

кафедра терапии Медицинского факультета

Санкт-Петербургский государственный университетRussian Federation2009100320091332432Copyright © Шишкин А.Н., Лындина М.Л., 20092009Шишкин А.Н., Лындина М.Л.Shishkin A.N., Lyndina M.L.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://journal.nephrolog.ru/jour/article/view/1174

В статье представлены данные о патогенезе возникновения дисфункции эндотелия при метаболическом синдроме. Описаны клинические и патогенетические особенности эндотелиальной дисфункции. Освещена проблема методов диагностики функции эндотелия. Показана роль микроальбуминурии. Представлены возможные подходы к терапии.

The article presents the data on pathogenesis of endothelial dysfunction in metabolic syndrome. Clinical and pathogenetic features of endothelial dysfunction are described. The problem of methods for diagnostics of endothelial dysfunction is covered. The role of microalbuminuria is shown. Probable approaches to the treatment of endothelial dysfunction are submitted.

метаболический синдромэндотелиальная дисфункциямикроальбуминурияэндотелий-зависимая вазодилатацияподходы к лечениюmetabolic syndromeendothelial dysfunctionmicroalbuminuriaendothelium-dependent vasodilationprobable approaches to therapyReferencesСтроев ЮИ, Цой МВ, Чурилов ЛП, Шишкин АН. Классические и современные представления о метаболическом синдроме. Часть 1. Критерии, эпидемиология, этиология. Вестник СПбГУ, серия 11; 2007 (1): 13-16Строев ЮИ, Цой МВ, Чурилов ЛП, Шишкин АН. Классические и современные представления о метаболическом синдроме. Часть 1. Критерии, эпидемиология, этиология. Вестник СПбГУ, серия 11; 2007 (1): 13-16Ford ES, Giles WH, Dietz WH. Prevalence of the metabolic syndrome among US adults: findings from the third National Healthhand Nutrition Examination Survey. JAMA 2002; 287: 356-359Ford ES, Giles WH, Dietz WH. Prevalence of the metabolic syndrome among US adults: findings from the third National Healthhand Nutrition Examination Survey. JAMA 2002; 287: 356-359Lemieux I, Pascot A, Couillard C et. al. Hypertriglyceridemic waist: a marker of the atherogenicmetabolic triad (hyperinsulinemia; hyperapolipoprotein B; small, dense LDL) in men? Circulation 2000; 102: 179-184Lemieux I, Pascot A, Couillard C et. al. Hypertriglyceridemic waist: a marker of the atherogenicmetabolic triad (hyperinsulinemia; hyperapolipoprotein B; small, dense LDL) in men? Circulation 2000; 102: 179-184Dunstan DW, Zimmet PZ, Welborn TA et al. The rising prevalence of diabetes and impaired glucose tolerance: The Australian Diabetes, Obesity and Lifestyle Study. Diabetes Care 2002; 25: 829-34Dunstan DW, Zimmet PZ, Welborn TA et al. The rising prevalence of diabetes and impaired glucose tolerance: The Australian Diabetes, Obesity and Lifestyle Study. Diabetes Care 2002; 25: 829-34Reaven GM. Role of insulin resistance in human disease. Diabetes 1988; 37: 1595-1607Reaven GM. Role of insulin resistance in human disease. Diabetes 1988; 37: 1595-1607Бутрова СА. Метаболический синдром и роль абдоминального ожирения в его развитии (вопросы патогенеза, проявления, современные подходы к лечению). Ожирение. Метаболический синдром. Сахарный диабет 2 типа. Под ред. ИИ Дедова. М., 2000: 38-43Бутрова СА. Метаболический синдром и роль абдоминального ожирения в его развитии (вопросы патогенеза, проявления, современные подходы к лечению). Ожирение. Метаболический синдром. Сахарный диабет 2 типа. Под ред. ИИ Дедова. М., 2000: 38-43Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults: Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) Adult Treatment Panel III. JAMA 2001; 285: 2486-2497Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults: Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) Adult Treatment Panel III. JAMA 2001; 285: 2486-2497Kahn R, Buse J, Ferrannini E, Stern M. The metabolic syndrome: time for critical appraisal: Joint statement of ADA and EASD. Diabetologia 2005; 48: 1684-1699Kahn R, Buse J, Ferrannini E, Stern M. The metabolic syndrome: time for critical appraisal: Joint statement of ADA and EASD. Diabetologia 2005; 48: 1684-1699International Diabetes Federation. Promoting diabetes care, prevention and cure worldwide. Backgrounder I. The IDP consensus worldwide definition of the metabolic syndrome. P. 1-7. [7 screens, 2 June 2005]International Diabetes Federation. Promoting diabetes care, prevention and cure worldwide. Backgrounder I. The IDP consensus worldwide definition of the metabolic syndrome. P. 1-7. [7 screens, 2 June 2005]Зайчик АШ, Чурилов ЛП, Строев ЮИ. Понятие о метаболическом синдроме. Патофизиология. Т. II. Патохимия. Патофизиология эндокринной системы и метаболизма.3-е изд. СПб., 2007Зайчик АШ, Чурилов ЛП, Строев ЮИ. Понятие о метаболическом синдроме. Патофизиология. Т. II. Патохимия. Патофизиология эндокринной системы и метаболизма.3-е изд. СПб., 2007Иванова ОВ, Соболева ГН, Карпов ЮА. Эндотелиальная дисфункция – важный этап развития атеросклеротического поражения сосудов (обзор литературы – 1). Тер арх 1997; (6): 75-78Иванова ОВ, Соболева ГН, Карпов ЮА. Эндотелиальная дисфункция – важный этап развития атеросклеротического поражения сосудов (обзор литературы – 1). Тер арх 1997; (6): 75-78Adams MR, Robinson J, McCredie R, Seale JP et al. Smooth muscle dysfunction occurs independently of impaired endothelium-dependent dilation in adults at risk of atherosclerosis. J Am Coll Cardiol 1998; 32(1): 123-127Adams MR, Robinson J, McCredie R, Seale JP et al. Smooth muscle dysfunction occurs independently of impaired endothelium-dependent dilation in adults at risk of atherosclerosis. J Am Coll Cardiol 1998; 32(1): 123-127Cai H, Harrison DG. Endothelial dysfunction in cardiovascular diseases. The role of oxidant stress. Circ Res 2000; 87:840-844Cai H, Harrison DG. Endothelial dysfunction in cardiovascular diseases. The role of oxidant stress. Circ Res 2000; 87:840-844Ройтберг ГЕ. Метаболический синдром. МЕД-пресс – информ, М., 2007Ройтберг ГЕ. Метаболический синдром. МЕД-пресс – информ, М., 2007Панина ИЮ, Румянцев АШ, Меншутина МА и др. Особенности функции эндотелия при хронической болезни почек. Обзор литературы и собственные данные. Нефрология 2007; 11 (4): 28-42Панина ИЮ, Румянцев АШ, Меншутина МА и др. Особенности функции эндотелия при хронической болезни почек. Обзор литературы и собственные данные. Нефрология 2007; 11 (4): 28-42Петрищев НН, Власов ТД. Физиология и патофизиология эндотелия. В: Петрищев Н.Н., ред. Дисфункция эндотелия. Причины, механизмы, фармакологическая коррекция. Изд-во СПбГМУ, СПб., 2003; 4-38Петрищев НН, Власов ТД. Физиология и патофизиология эндотелия. В: Петрищев Н.Н., ред. Дисфункция эндотелия. Причины, механизмы, фармакологическая коррекция. Изд-во СПбГМУ, СПб., 2003; 4-38Петрищев НН. Современные аспекты эндотелиопротекции в клинической практике. Ангиопротекция в практике терапевта: Материалы III Конгресса терапевтов Санкт-Петербурга и Северо-Западного Федерального округа России. СПб., 2004; 3-6Петрищев НН. Современные аспекты эндотелиопротекции в клинической практике. Ангиопротекция в практике терапевта: Материалы III Конгресса терапевтов Санкт-Петербурга и Северо-Западного Федерального округа России. СПб., 2004; 3-6Britten MB, Zeiher AM, Schachinger V. Clinical importance of coronary endothelial vasodilator dysfunction and therapeutic options. J Intern Med 1999; 245(4): 315-321Britten MB, Zeiher AM, Schachinger V. Clinical importance of coronary endothelial vasodilator dysfunction and therapeutic options. J Intern Med 1999; 245(4): 315-321Шишкин АН, Кирилюк ДВ. Дисфункция эндотелия у пациентов с прогрессирующими заболеваниями почек. Нефрология 2005; 9(2): 16-22Шишкин АН, Кирилюк ДВ. Дисфункция эндотелия у пациентов с прогрессирующими заболеваниями почек. Нефрология 2005; 9(2): 16-22Noguera A, Busquets X, Sauleda J et al. Expression of adhesion molecules and G proteins in circulating neutrophils in chronic pulmonary disease. Am J Crit Care Med 1998; 158(5): 1664-1668Noguera A, Busquets X, Sauleda J et al. Expression of adhesion molecules and G proteins in circulating neutrophils in chronic pulmonary disease. Am J Crit Care Med 1998; 158(5): 1664-1668Гомазков ОА. Пептиды в кардиологии. Биохимия. Физиология. Патология. Информация. Анализ. Материк Альфа, М., 2000; 143Гомазков ОА. Пептиды в кардиологии. Биохимия. Физиология. Патология. Информация. Анализ. Материк Альфа, М., 2000; 143Дедов ИИ, Шестакова МВ, Кочемасова ТВ и др. Дисфункция эндотелия в развитии сосудистых осложнений сахарного диабета. Рос физиол журн им И. М. Сеченова 2001; 87(8): 1073-1084Дедов ИИ, Шестакова МВ, Кочемасова ТВ и др. Дисфункция эндотелия в развитии сосудистых осложнений сахарного диабета. Рос физиол журн им И. М. Сеченова 2001; 87(8): 1073-1084Shirahase H, Fujiwara M, Usui H, Kurahashi K. A possible role of thromboxane A2 in endothelium in maintaining resting tone and producing contractile response to acetylcholine and arachidonic acid in canine cerebral artery. Blood Vessels 1987; 24: 117-119Shirahase H, Fujiwara M, Usui H, Kurahashi K. A possible role of thromboxane A2 in endothelium in maintaining resting tone and producing contractile response to acetylcholine and arachidonic acid in canine cerebral artery. Blood Vessels 1987; 24: 117-119Kato T, Iwama I, Okumura K et al. Prostaglandin H2 may be the endothelium-derived contracting factor released by acetylcholine in the aorta of the rat. Hypertension 1990; 15: 475-482Kato T, Iwama I, Okumura K et al. Prostaglandin H2 may be the endothelium-derived contracting factor released by acetylcholine in the aorta of the rat. Hypertension 1990; 15: 475-482Marie I, Beny JL. Endothelial dysfunction in murine model of systemic sclerosis. J Invest Dermatol 2002; 119 (6): 1379-1385Marie I, Beny JL. Endothelial dysfunction in murine model of systemic sclerosis. J Invest Dermatol 2002; 119 (6): 1379-1385Feletou M, Busse R, Edwards G et al. Med Sci 2003; 19: 1242-1250Feletou M, Busse R, Edwards G et al. Med Sci 2003; 19: 1242-1250Реутов ВП, Сорокина ЕГ, Косицын НС. Успехи современной биологии 2005; 25(1): 41-65Реутов ВП, Сорокина ЕГ, Косицын НС. Успехи современной биологии 2005; 25(1): 41-65Ванин АФ. Биохимия. 1998; 63(7): 867-869Ванин АФ. Биохимия. 1998; 63(7): 867-869Becker RC. The role of blood viscosity in the development and progression of coronary artery disease. Cleve Clin J Med 1993; 60(5): 353-358Becker RC. The role of blood viscosity in the development and progression of coronary artery disease. Cleve Clin J Med 1993; 60(5): 353-358Feletou M, Vanhoutte PM. The alternative: EDHF. J Mol Cell Cardiol 1999 (31): 15-22Feletou M, Vanhoutte PM. The alternative: EDHF. J Mol Cell Cardiol 1999 (31): 15-22Bergman R. Non-esterified fatty acids and the liver: why is insulin secreted into the portal vein? Diabetologia 2000; 43: 946-953Bergman R. Non-esterified fatty acids and the liver: why is insulin secreted into the portal vein? Diabetologia 2000; 43: 946-953Петрищев НН, ред. Дисфункция эндотелия. Причины, механизмы, фармакологическая коррекция. СПб., 2003; 4-39Петрищев НН, ред. Дисфункция эндотелия. Причины, механизмы, фармакологическая коррекция. СПб., 2003; 4-39Paloshi A, Fragasso G, Piatti P, et al. Effect of oral L-arginine on blood pressure and symptoms and endothelial function in patients with systemic hypertension, positive exercise tests, and normal coronary arteries. Am J Cardiol 2004; 93(7): 933-935Paloshi A, Fragasso G, Piatti P, et al. Effect of oral L-arginine on blood pressure and symptoms and endothelial function in patients with systemic hypertension, positive exercise tests, and normal coronary arteries. Am J Cardiol 2004; 93(7): 933-935Шестакова МВ. Дисфункция эндотелия – причина или следствие метаболического синдрома? РМЖ 2001; 9(2): 32-35Шестакова МВ. Дисфункция эндотелия – причина или следствие метаболического синдрома? РМЖ 2001; 9(2): 32-35Lippincott MF, Carlow A, Desai A, Blum A, Rodrigo M, et al. Relation of endothelial function to cardiovascular risk in women with sedentary occupations and without known cardiovascular disease. Am Coll Cardiol 2008; 102, (3): 643-647Lippincott MF, Carlow A, Desai A, Blum A, Rodrigo M, et al. Relation of endothelial function to cardiovascular risk in women with sedentary occupations and without known cardiovascular disease. Am Coll Cardiol 2008; 102, (3): 643-647Li TY, Rana JS, Manson JE, Willett WC, Stampfer MJ, Colditz GA, Rexrode KM, Hu FB. Obesity as compared with physical activity in predicting risk of coronary heart disease in women. Circulation 2006; 113: 499-506Li TY, Rana JS, Manson JE, Willett WC, Stampfer MJ, Colditz GA, Rexrode KM, Hu FB. Obesity as compared with physical activity in predicting risk of coronary heart disease in women. Circulation 2006; 113: 499-506Suzuki T, Hirata K, Elkind MSV et al. Metabolic syndrome, endothelial dysfunction, and risk of cardiovascular events: the northern Manhattan study (NOMAS). Am Heart J2008; 156: 405-10Suzuki T, Hirata K, Elkind MSV et al. Metabolic syndrome, endothelial dysfunction, and risk of cardiovascular events: the northern Manhattan study (NOMAS). Am Heart J2008; 156: 405-10Patel VA., Zhang QJ, Siddle K, Seos MA, Goddard M, Weissberg PL, Benett MR: Defect in insulin-like growth factor-I survival mechanisms in atherosclerotic plaque-derived vascular smooth muscle cells is mediated by reduced surface binding and signaling. Circ Res 2001; 88: 895-902Patel VA., Zhang QJ, Siddle K, Seos MA, Goddard M, Weissberg PL, Benett MR: Defect in insulin-like growth factor-I survival mechanisms in atherosclerotic plaque-derived vascular smooth muscle cells is mediated by reduced surface binding and signaling. Circ Res 2001; 88: 895-902Reaven GM, Lithell H, Landsberg L. Hypertension and associated metabolic abnormalities – the role of insulin resistance and the sympathoadrenal system. N Engl J Med 1996; 334: 374-381Reaven GM, Lithell H, Landsberg L. Hypertension and associated metabolic abnormalities – the role of insulin resistance and the sympathoadrenal system. N Engl J Med 1996; 334: 374-381Spallarossa P, Brunelli C, Minuto F et al. Insulin-like growth factor-I and angiographically documented coronary artery disease. Am J Cardiol 1996; 77: 200-202Spallarossa P, Brunelli C, Minuto F et al. Insulin-like growth factor-I and angiographically documented coronary artery disease. Am J Cardiol 1996; 77: 200-202Janssen J, Stolk RP, Pols H, Grobbee DE, Lamberts SW. Serum total IGF-I, free IGF-I, and IGFBP-I levels in an elderly population: relation to cardiovascular risk factors and disease. Arterioscler Thromb Vasc Biol [Erratum (1998) 18:1197] 1998; 18: 277-282Janssen J, Stolk RP, Pols H, Grobbee DE, Lamberts SW. Serum total IGF-I, free IGF-I, and IGFBP-I levels in an elderly population: relation to cardiovascular risk factors and disease. Arterioscler Thromb Vasc Biol [Erratum (1998) 18:1197] 1998; 18: 277-282Van den Beld AW, Bots ML et al. Endogenous hormones and carotid atherosclerosis in elderly men. Am J Epidemiol 2003; 157: 25-31Van den Beld AW, Bots ML et al. Endogenous hormones and carotid atherosclerosis in elderly men. Am J Epidemiol 2003; 157: 25-31Juul A, Scheike T, Davidsen M, Gyllenborg J, Jorgensen T. Low serum insulin-like growth factor 1 is associated with increased risk of ischemic heart disease: a population-based case-control study. Circulation 2002; 106: 939-944Juul A, Scheike T, Davidsen M, Gyllenborg J, Jorgensen T. Low serum insulin-like growth factor 1 is associated with increased risk of ischemic heart disease: a population-based case-control study. Circulation 2002; 106: 939-944Laughlin GA, Barrett-Connor E, Criqui MH, Kritz-Silverstein D: The prospective association of serum insulin-like growth factor I (IGF-I) and IGF-binding protein-1 levels with all cause and cardiovascular disease mortality in older adults: the Rancho Bernardo Study. J Clin Endocrinol Metab 2004; 89: 114-120Laughlin GA, Barrett-Connor E, Criqui MH, Kritz-Silverstein D: The prospective association of serum insulin-like growth factor I (IGF-I) and IGF-binding protein-1 levels with all cause and cardiovascular disease mortality in older adults: the Rancho Bernardo Study. J Clin Endocrinol Metab 2004; 89: 114-120Johnsen SP, Hundborg HH, Sorensen HT et al. Insulin-like growth factor (IGF) I,-II, and IGF binding protein-3 and risk of ischemic stroke. J Clin Endocrinol Metab 2005; 90: 5937-5941Johnsen SP, Hundborg HH, Sorensen HT et al. Insulin-like growth factor (IGF) I,-II, and IGF binding protein-3 and risk of ischemic stroke. J Clin Endocrinol Metab 2005; 90: 5937-5941Kaplan RC, McGinn AP, Pollak MN et al. Association of total insulin-like growth factor-I, insulin-like growth factor binding protein-1 (IGFBP-1), and IGFBP-3 levels with incident coronary events and ischemic stroke. J Clin Endocrinol Metab 2007; 92: 1319-1325Kaplan RC, McGinn AP, Pollak MN et al. Association of total insulin-like growth factor-I, insulin-like growth factor binding protein-1 (IGFBP-1), and IGFBP-3 levels with incident coronary events and ischemic stroke. J Clin Endocrinol Metab 2007; 92: 1319-1325Perticone F, Sciacqua A, Perticone M et al. Low-plasma insulin-like growth factor-I levels are associated with impaired endothelium-dependent vasodilatation in a cohort of untreated, hypertensive Caucasian subjects. J Clin Endoc Metab 2008; 92 (7): 1567-1572Perticone F, Sciacqua A, Perticone M et al. Low-plasma insulin-like growth factor-I levels are associated with impaired endothelium-dependent vasodilatation in a cohort of untreated, hypertensive Caucasian subjects. J Clin Endoc Metab 2008; 92 (7): 1567-1572Шишкин АН. Дисфункция эндотелия и микроальбуминурия. Клиническое значение и терапевтические подходы. Передовые медицинские технологии практическому здравоохранению. СПб., 2008; 193-199Шишкин АН. Дисфункция эндотелия и микроальбуминурия. Клиническое значение и терапевтические подходы. Передовые медицинские технологии практическому здравоохранению. СПб., 2008; 193-199Karalliedde J, Viberti G. Microalbuminuria and cardiovascular risk. Am J Hipertens 2004; 17:986-993Karalliedde J, Viberti G. Microalbuminuria and cardiovascular risk. Am J Hipertens 2004; 17:986-993Valmadrid CT, Klein R, Moss SE, Klein BE. The risk of cardiovascular disease mortality associated with microalbuminuria and gross proteinuria in persons with older-onset diabetes mellitus. Arch Intern Med 2000; 160: 1093-1100Valmadrid CT, Klein R, Moss SE, Klein BE. The risk of cardiovascular disease mortality associated with microalbuminuria and gross proteinuria in persons with older-onset diabetes mellitus. Arch Intern Med 2000; 160: 1093-1100Gerstein HC, Mann JF, Yi Q et al. Albuminuria and risk of cardiovascular events, death and heart failure in diabetic and nondiabetic individuals. JAMA 2001; 286: 421-426Gerstein HC, Mann JF, Yi Q et al. Albuminuria and risk of cardiovascular events, death and heart failure in diabetic and nondiabetic individuals. JAMA 2001; 286: 421-426Wachtell K, Ibsen H, Olsen MH et al. Albuminuria and cardiovascular risk in hypertensive patients with left ventricular hypertrophy: the LIFE study. Am Intern Med 2003; 139:901-906Wachtell K, Ibsen H, Olsen MH et al. Albuminuria and cardiovascular risk in hypertensive patients with left ventricular hypertrophy: the LIFE study. Am Intern Med 2003; 139:901-906Wachtell K, Palmieri V, Olsen MH et al. Urine albumin/creatinine ratio and echocardiographic left ventricular structure and function in hypertensive patients with electrocardiographic left ventricular hypertrophy: the LIFE study. Losartan Intervention for Endpoint Reduction. Am Heart J 2002; 143:319-326Wachtell K, Palmieri V, Olsen MH et al. Urine albumin/creatinine ratio and echocardiographic left ventricular structure and function in hypertensive patients with electrocardiographic left ventricular hypertrophy: the LIFE study. Losartan Intervention for Endpoint Reduction. Am Heart J 2002; 143:319-326Ravera M, Ratto E, Vettoretti S et al. Microalbuminuria and subclinical cerebrovascular damage in essential hypertension. J Nephrol 2002; 15:519-524Ravera M, Ratto E, Vettoretti S et al. Microalbuminuria and subclinical cerebrovascular damage in essential hypertension. J Nephrol 2002; 15:519-524Bianchi S, Bigazzi R, Campese VM. Microalbuminuria in essential hypertension: significance, pathophisiology, and therapeutic implications. Am J Kidney Dis 1999; 34:973-995Bianchi S, Bigazzi R, Campese VM. Microalbuminuria in essential hypertension: significance, pathophisiology, and therapeutic implications. Am J Kidney Dis 1999; 34:973-995American Diabetes Association: Standards of medical care in diabetes – 2008. Diabetes Care 2008; 31[suppl. I]: S12-S54American Diabetes Association: Standards of medical care in diabetes – 2008. Diabetes Care 2008; 31[suppl. I]: S12-S54Volpe M. Microalbuminuria screening in patients with hypertension: recommendation for clinical practice. Int J Clin Pract 2008; 62(1): 97-108Volpe M. Microalbuminuria screening in patients with hypertension: recommendation for clinical practice. Int J Clin Pract 2008; 62(1): 97-108Jassal SK, Langenberg C, von Muhlen D, Bergstrom J, Barett-Connor E. Usefulness of microalbuminuria versus the metabolic syndrome as a predictor of cardiovascular disease in women and men > 40 tears of age (from the Rancho Bernardo Study). Am J Cardiol 2008; 101:1275-1280Jassal SK, Langenberg C, von Muhlen D, Bergstrom J, Barett-Connor E. Usefulness of microalbuminuria versus the metabolic syndrome as a predictor of cardiovascular disease in women and men > 40 tears of age (from the Rancho Bernardo Study). Am J Cardiol 2008; 101:1275-1280Gimeno-Orna JA. Microalbuminuria accounts for the increased vascular disease risk in diabetic patients with metabolic syndrome. Rev Esp Cardiol 2007; 60(11):1202-1205Gimeno-Orna JA. Microalbuminuria accounts for the increased vascular disease risk in diabetic patients with metabolic syndrome. Rev Esp Cardiol 2007; 60(11):1202-1205Diercks GF, Stroes ES, van Boven AJ, et al. Urinary albumin excretion is related to cardiovascular risk indicators, not to flow-mediated vasodilation. In apparently healthy subjects. Atherosclerosis 2002; 163(1):121-126Diercks GF, Stroes ES, van Boven AJ, et al. Urinary albumin excretion is related to cardiovascular risk indicators, not to flow-mediated vasodilation. In apparently healthy subjects. Atherosclerosis 2002; 163(1):121-126Clausen P, Jensen JS, Jensen G, et al. Elevated urinary albumin excretion is associated with impaired arterial dilatory capacity in clinically healthy subjects. Circulation 2001; 103(14): 1869-1874Clausen P, Jensen JS, Jensen G, et al. Elevated urinary albumin excretion is associated with impaired arterial dilatory capacity in clinically healthy subjects. Circulation 2001; 103(14): 1869-1874Шишкин АН. Современная стратегия терапии эндотелиальной дисфункции с позиции доказательной медицины. Новые Санкт-Петербургские Врачебные Ведомости 2008 (3): 16-19Шишкин АН. Современная стратегия терапии эндотелиальной дисфункции с позиции доказательной медицины. Новые Санкт-Петербургские Врачебные Ведомости 2008 (3): 16-19Anderson TJ, Meredith IT, Yeung AC et al. The effect of cholesterol-lowering and antioxidant therapy on endothelium-dependent coronary vasomotion. N Engl J Med 1995; 332(8): 488-493Anderson TJ, Meredith IT, Yeung AC et al. The effect of cholesterol-lowering and antioxidant therapy on endothelium-dependent coronary vasomotion. N Engl J Med 1995; 332(8): 488-493Roque M, Heras M, Roig E, et al. Short-term effects of transdermal estrogen replacement therapy on coronary vascular reactivity in post-menopausal women with angina pectoris and normal results on coronary angiograms. J Am Coll Cardiol 1998; 31(1): 139-143Roque M, Heras M, Roig E, et al. Short-term effects of transdermal estrogen replacement therapy on coronary vascular reactivity in post-menopausal women with angina pectoris and normal results on coronary angiograms. J Am Coll Cardiol 1998; 31(1): 139-143Kaski JС. Overview of gender aspects of cardiac syndrome X. Cardiovasc Res 2002; 53(3): 620-626Kaski JС. Overview of gender aspects of cardiac syndrome X. Cardiovasc Res 2002; 53(3): 620-626Rosano GM, Peters NS, Lefroy D, et al. 17-beta-estradiol therapy lessens angina in postmenopausal women with syndrome X. J Am Coll Cardiol 1996; 28(6):1500-1505Rosano GM, Peters NS, Lefroy D, et al. 17-beta-estradiol therapy lessens angina in postmenopausal women with syndrome X. J Am Coll Cardiol 1996; 28(6):1500-1505Knoops KT, de Groot LC, Kromhout D et al. Mediterranean diet, lifestyle factors, and 10-year mortality in elderly European men and women: the HALE project. JAMA 2004; 292(12): 1433-1439Knoops KT, de Groot LC, Kromhout D et al. Mediterranean diet, lifestyle factors, and 10-year mortality in elderly European men and women: the HALE project. JAMA 2004; 292(12): 1433-1439Gokce N, Vita JA, McDonnell M et al. Effect of medical and surgical weight loss on endothelial vasomotor function in obese patients. Am J Cardiol 2005; 95(2): 266-268Gokce N, Vita JA, McDonnell M et al. Effect of medical and surgical weight loss on endothelial vasomotor function in obese patients. Am J Cardiol 2005; 95(2): 266-268Raitakari OT, Adams MR, McCredie RJ, Griffiths KA, Celermajer DC. Arterial endothelial dysfunction related to passive smoking is potentially reversible in healthy young adults. Ann Intern Med 1999; 130(7): 578-581Raitakari OT, Adams MR, McCredie RJ, Griffiths KA, Celermajer DC. Arterial endothelial dysfunction related to passive smoking is potentially reversible in healthy young adults. Ann Intern Med 1999; 130(7): 578-581Мухин НА, Арутюнов ГП, Фомин ВВ. Альбуминурия – маркер поражения почек и риска сердечно-сосудистых осложнений. Клиническая нефрология 2009 (1): 5-10Мухин НА, Арутюнов ГП, Фомин ВВ. Альбуминурия – маркер поражения почек и риска сердечно-сосудистых осложнений. Клиническая нефрология 2009 (1): 5-10

The authors declare that there are no conflicts of interest present.